These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8096419)

  • 21. Comparison of white blood cell dyscrasias during sulphasalazine therapy of rheumatoid arthritis and inflammatory bowel disease.
    Capell HA; Pullar T; Hunter JA
    Drugs; 1986; 32 Suppl 1():44-8. PubMed ID: 2877852
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adverse interaction between intramuscular methylprednisolone and sulphasalazine in patients with early rheumatoid arthritis. A pilot study.
    Gough A; Sheeran T; Arthur V; Panayi G; Emery P
    Scand J Rheumatol; 1994; 23(1):46-8. PubMed ID: 7906428
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sulphasalazine in rheumatoid arthritis: a double blind comparison of sulphasalazine with placebo and sodium aurothiomalate.
    Pullar T; Hunter JA; Capell HA
    Br Med J (Clin Res Ed); 1983 Oct; 287(6399):1102-4. PubMed ID: 6138117
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Experiences in long-term therapy of rheumatoid arthritis with sulfasalazine tablets].
    Amos RS
    Z Rheumatol; 1987; 46(2):76-8. PubMed ID: 2885988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sulphasalazine in rheumatic diseases.
    Dougados M
    Agents Actions Suppl; 1993; 44():197-201. PubMed ID: 8103962
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does sulphasalazine cause drug induced systemic lupus erythematosus? No effect evident in a prospective randomised trial of 200 rheumatoid patients treated with sulphasalazine or auranofin over five years.
    Gordon MM; Porter DR; Capell HA
    Ann Rheum Dis; 1999 May; 58(5):288-90. PubMed ID: 10225813
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison between penicillamine and sulphasalazine in rheumatoid arthritis: Leeds-Birmingham trial.
    Neumann VC; Grindulis KA; Hubball S; McConkey B; Wright V
    Br Med J (Clin Res Ed); 1983 Oct; 287(6399):1099-102. PubMed ID: 6138116
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination of methotrexate and sulphasalazine vs methotrexate alone: a randomized open clinical trial in rheumatoid arthritis patients resistant to sulphasalazine therapy.
    Haagsma CJ; van Riel PL; de Rooij DJ; Vree TB; Russel FJ; van't Hof MA; van de Putte LB
    Br J Rheumatol; 1994 Nov; 33(11):1049-55. PubMed ID: 7981992
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Raised serum alkaline phosphatase and aspartate transaminase levels in two rheumatoid patients treated with sulphasalazine.
    Farr M; Symmons DP; Bacon PA
    Ann Rheum Dis; 1985 Nov; 44(11):798-800. PubMed ID: 2865931
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of acetylator phenotype on efficacy and toxicity of sulphasalazine in rheumatoid arthritis.
    Pullar T; Hunter JA; Capell HA
    Ann Rheum Dis; 1985 Dec; 44(12):831-7. PubMed ID: 2867746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sulphasalazine therapy in rheumatoid arthritis. A two-year study and follow-up of clinical results.
    Georgescu C
    Rom J Intern Med; 1992; 30(2):127-32. PubMed ID: 1353901
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of sulphasalazine plus methotrexate in rheumatoid arthritis.
    Islam MN; Alam MN; Haq SA; Moyenuzzaman M; Patwary MI; Rahman MH
    Bangladesh Med Res Counc Bull; 2000 Apr; 26(1):1-7. PubMed ID: 11192489
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Variables affecting efficacy and toxicity of sulphasalazine in rheumatoid arthritis. A review.
    Pullar T; Capell HA
    Drugs; 1986; 32 Suppl 1():54-7. PubMed ID: 2877854
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the single dose pharmacokinetics of sulphasalazine in rheumatoid arthritis and inflammatory bowel disease.
    Astbury C; Taggart AJ; Juby L; Zebouni L; Bird HA
    Ann Rheum Dis; 1990 Aug; 49(8):587-90. PubMed ID: 1975737
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Leucopenia during sulphasalazine treatment for rheumatoid arthritis.
    Marabani M; Madhok R; Capell HA; Hunter JA
    Ann Rheum Dis; 1989 Jun; 48(6):505-7. PubMed ID: 2568110
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Degree and extent of response to sulphasalazine or penicillamine therapy for rheumatoid arthritis: results from a routine clinical environment over a two-year period.
    Capell HA; Marabani M; Madhok R; Torley H; Hunter JA
    Q J Med; 1990 Apr; 75(276):335-44. PubMed ID: 1974723
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sulphasalazine-induced systemic lupus erythematosus in a patient with erosive arthritis.
    Walker EM; Carty JE
    Br J Rheumatol; 1994 Feb; 33(2):175-6. PubMed ID: 7909272
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fatal neutropenic enterocolitis associated with sulphasalazine therapy for rheumatoid arthritis.
    Chakravarty K; Scott DG; McCann BG
    Br J Rheumatol; 1992 May; 31(5):351-3. PubMed ID: 1349846
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sulphasalazine: a safe, effective agent for prolonged control of rheumatoid arthritis. A comparison with sodium aurothiomalate.
    Bax DE; Amos RS
    Ann Rheum Dis; 1985 Mar; 44(3):194-8. PubMed ID: 2858182
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sulphasalazine in rheumatoid arthritis: desensitising the patient with a skin rash.
    Bax DE; Amos RS
    Ann Rheum Dis; 1986 Feb; 45(2):139-40. PubMed ID: 2868699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.